Pathology Asia Holdings
Asia, Central Region, Singapore, Singapore'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Description
Pathology Asia Holdings is a medical diagnostics group.
Investor Profile
Pathology Asia Holdings has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biopharma, Biotechnology, Health Care.
Stage Focus
- Series C (100%)
Country Focus
- United States (100%)
Industry Focus
- Biopharma
- Biotechnology
- Health Care
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Which angels does Pathology Asia Holdings often collaborate with?
What are some of recent deals done by Pathology Asia Holdings?
Find More Investors Like Pathology Asia Holdings
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
